Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 22, 2021 | Innoforce Pharmaceuticals | $142.1M Series A / Series D | Capital Venture Investment Fund | — |
| Nov 6, 2020 | Yuntongxun | $120.0M Series F | Capital Venture Investment Fund | — |